Stereotactic body radiation therapy for low-, intermediate- and high-risk prostate cancer: Disease control and quality of life at 9 years. EORTC trial 22991: Results of a phase III study comparing 6 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback